Invention Grant
- Patent Title: CXC chemokine receptor 4 (CXCR4) antagonistic polypeptide
- Patent Title (中): CXC趋化因子受体4（CXCR4）拮抗多肽
-
Application No.: US12452480Application Date: 2008-07-03
-
Publication No.: US09045563B2Publication Date: 2015-06-02
- Inventor: Wolf-Georg Forssmann , Frank Kirchhoff , Jan Münch , Ludger Ständker
- Applicant: Wolf-Georg Forssmann , Frank Kirchhoff , Jan Münch , Ludger Ständker
- Applicant Address: DE Hannover
- Assignee: PHARIS BIOTECH GMBH
- Current Assignee: PHARIS BIOTECH GMBH
- Current Assignee Address: DE Hannover
- Agency: Jacobson Holman PLLC
- Priority: DE102007030904 20070703
- International Application: PCT/EP2008/058566 WO 20080703
- International Announcement: WO2009/004054 WO 20090108
- Main IPC: C07K14/435
- IPC: C07K14/435 ; C07K14/765 ; A61K38/00
Abstract:
A peptide having the following amino acid sequence: Z1-LVRYTKKVPQVSTPTL-Z2(ALB-408) and its biologically active fragments and/or variants and/or derivatives, especially amidated, acetylated, sulfated, phosphorylated and/or glycosylated derivatives, and peptides obtainable by multiple synthesis which have the biological activity of ALB408-423; wherein Z represents number of from 0 to 10 amino acid residues.
Public/Granted literature
- US20130029902A1 CXC CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONISTIC POLYPEPTIDE Public/Granted day:2013-01-31
Information query
